RightFit
RecruitingNot applicable

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing): Optimization and Evaluation Using Multiphase Optimization Strategy (MOST) and Social Network Analysis (SNA)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years to 75 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests which mix of family support works best for weight loss in Black adults. It compares family communication, closeness, the number of sessions, and how sessions are held. Participants and their family partners join a 6-month program with in-person weight loss groups, family sessions, and tracking of weight, food, and activity.

The goal of this clinical trial is to learn the best combination of family components that yields optimal weight loss among Black adults. The main question it aims to answer is: What combination of four family components in combination with a standard behavioral weight loss program yields optimal weight loss among Black adults? Researchers will compare different combinations of family skills components (communication content, cohesion content, number of sessions, and mode of delivery) to see the best weight loss. Participants will: * Participate in a 6-month behavioral weight loss intervention * Attend core weight loss in-person group sessions, and dyad based family sessions * Keep track of weight, dietary intake and physical activity

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • The main participant identifies as Black or African American.
  • The main participant has a BMI of 30 or higher; the family partner has a BMI of 27.5 or higher. BMI is a measure based on height and weight.
  • Have a partner or family member willing to join, with a shared goal of losing weight.
  • Speak English.
  • Be 18 to 75 years old. Any gender may join.
  • Have access to and be able to use a smartphone, tablet, or computer with internet access.
  • Be able to change the foods you eat.

Who can't join

  • Plan to move out of the area in the next 8–9 months.
  • Joined a weight loss program with more than 12 visits in the past year, or lost more than 20 pounds in the past 6 months.
  • Had weight loss surgery in the past 2 years or are considering it in the next 8–9 months. Also excluded: using prescription weight loss drugs now or in the past 3 months, or planning to start drugs for weight loss.
  • Have type 1 diabetes or report advanced kidney disease, with a kidney filtering rate called GFR below 30 mL/min.
  • Have depression or another major mental illness that is not well managed with counseling, medicine, or both.
  • Are pregnant, plan to become pregnant in the next 8–9 months, or are breastfeeding a baby younger than 3 months.
  • Use alcohol or drugs in a way that disrupts work or causes major problems with family or social life more than twice a month.
  • Have cancer other than non-melanoma skin cancer, unless considered cured more than 5 years ago. Exceptions include men with prostate cancer that has not spread, treated with usual care or closely watched; and women past menopause taking added hormone-blocking treatment for hormone-sensitive breast cancer that has not spread.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * self-identified as Black or African American (Index participant) * BMI equal to greater than 30 kg/m\^2 (Index); BMI equal to greater than 27.5 kg/m\^2 (family partner) * have a partner/family member willing to enroll in the study and must share a mutual goal of achieving weight loss * English speaking * ages 18-75 * any gender * have access to and be able to use a smartphone, tablet, or computer that has web-access (this is required for data collection and some program components being tested) * able to make changes to the food you eat Exclusion Criteria: * planning to move out of the area with the next 8-9 months * participation in an intensive weight loss program (more than 12 visits) in the prior 12 months * type 1 diabetes * significant psychiatric illness, defined as depression or other major psychiatric illness not considered reasonably managed by counseling, medication, or both * had bariatric surgery (surgery for weight loss) in the last 2 years or considering bariatric surgery in the next 8-9 months * using or in the prior 3 months taking prescription weight loss medications, or planning to start medications intentionally for weight loss * lost more than 20 pounds of body weight in last 6 months * are pregnant or planning to get pregnant in the next 8-9 months * are breastfeeding an infant less than 3 months old * alcohol or substance abuse, defined as alcohol or substance use that interferes with work activities and/or has had a major negative impact on family/social function, the latter defined as more than 2 episodes per month. * malignancy other than non-melanoma skin cancer, unless considered cured \> 5 years ago. Exceptions include 1) men with localized prostate cancer (treated with usual modalities or managed with "active surveillance"), and 2) postmenopausal women receiving adjuvant endocrine therapy (e.g., aromatase inhibitor) for non-metastatic, hormone receptor-positive breast cancer * self-report of advanced kidney disease (estimated glomerular filtration rate (GFR) \< 30 mL/min)

Study sites (1)

NC